Please use this identifier to cite or link to this item: https://doi.org/10.1038/ncomms12493
Title: Inactivation of TGF? receptors in stem cells drives cutaneous squamous cell carcinoma
Authors: Cammareri, P
Rose, A.M
Vincent, D.F
Wang, J
Nagano, A
Libertini, S
Ridgway, R.A
Athineos, D
Coates, P.J
McHugh, A
Pourreyron, C
Dayal, J.H.S
Larsson, J
Weidlich, S
Spender, L.C
Sapkota, G.P
Purdie, K.J
Proby, C.M
Harwood, C.A
Leigh, I.M
Clevers, H
Barker, N 
Karlsson, S
Pritchard, C
Marais, R
Chelala, C
South, A.P
Sansom, O.J
Inman, G.J
Keywords: B Raf kinase
K ras protein
mitogen activated protein kinase
Smad2 protein
Smad3 protein
Smad4 protein
transforming growth factor beta receptor 1
transforming growth factor beta receptor 2
antineoplastic agent
B Raf kinase
indole derivative
protein p21
protein p53
protein serine threonine kinase
sulfonamide
TGF-beta type I receptor
transforming growth factor beta
transforming growth factor beta receptor
transforming growth factor-beta type II receptor
vemurafenib
cancer
cells and cell components
cytology
gene
genetic engineering
mutation
protein
rodent
skin
tumor
animal experiment
animal model
animal tissue
Article
controlled study
disease course
extracellular matrix
female
gene mutation
human
human tissue
male
mouse
nonhuman
signal transduction
skin carcinogenesis
skin carcinoma
stem cell
animal
antagonists and inhibitors
biopsy
carcinogenesis
chemically induced
dna mutational analysis
drug effect
experimental neoplasm
genetics
inbred mouse strain
melanoma
metabolism
mutation
pathology
procedures
skin tumor
squamous cell carcinoma
stem cell
tumor cell line
whole exome sequencing
Murinae
Animals
Antineoplastic Agents
Biopsy
Carcinogenesis
Carcinoma, Squamous Cell
Cell Line, Tumor
DNA Mutational Analysis
Female
Humans
Indoles
Male
Melanoma
Mice
Mice, Inbred Strains
Mutation
Neoplasms, Experimental
Protein-Serine-Threonine Kinases
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins p21(ras)
Receptors, Transforming Growth Factor beta
Signal Transduction
Skin Neoplasms
Stem Cells
Sulfonamides
Transforming Growth Factor beta
Tumor Suppressor Protein p53
Whole Exome Sequencing
Issue Date: 2016
Publisher: Nature Publishing Group
Citation: Cammareri, P, Rose, A.M, Vincent, D.F, Wang, J, Nagano, A, Libertini, S, Ridgway, R.A, Athineos, D, Coates, P.J, McHugh, A, Pourreyron, C, Dayal, J.H.S, Larsson, J, Weidlich, S, Spender, L.C, Sapkota, G.P, Purdie, K.J, Proby, C.M, Harwood, C.A, Leigh, I.M, Clevers, H, Barker, N, Karlsson, S, Pritchard, C, Marais, R, Chelala, C, South, A.P, Sansom, O.J, Inman, G.J (2016). Inactivation of TGF? receptors in stem cells drives cutaneous squamous cell carcinoma. Nature Communications 7 : 12493. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms12493
Rights: Attribution 4.0 International
Abstract: Melanoma patients treated with oncogenic BRAF inhibitors can develop cutaneous squamous cell carcinoma (cSCC) within weeks of treatment, driven by paradoxical RAS/RAF/MAPK pathway activation. Here we identify frequent TGFBR1 and TGFBR2 mutations in human vemurafenib-induced skin lesions and in sporadic cSCC. Functional analysis reveals these mutations ablate canonical TGF? Smad signalling, which is localized to bulge stem cells in both normal human and murine skin. MAPK pathway hyperactivation (through Braf V600E or Kras G12D knockin) and TGF? signalling ablation (through Tgfbr1 deletion) in LGR5 +ve stem cells enables rapid cSCC development in the mouse. Mutation of Tp53 (which is commonly mutated in sporadic cSCC) coupled with Tgfbr1 deletion in LGR5 +ve cells also results in cSCC development. These findings indicate that LGR5 +ve stem cells may act as cells of origin for cSCC, and that RAS/RAF/MAPK pathway hyperactivation or Tp53 mutation, coupled with loss of TGF? signalling, are driving events of skin tumorigenesis. © The Author(s) 2016.
Source Title: Nature Communications
URI: https://scholarbank.nus.edu.sg/handle/10635/182434
ISSN: 2041-1723
DOI: 10.1038/ncomms12493
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_ncomms12493.pdf1.9 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons